Literature DB >> 16595376

Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis.

Klemens Ruprecht1, Karola Obojes, Verena Wengel, Felix Gronen, Kwang Sik Kim, Hervé Perron, Jürgen Schneider-Schaulies, Peter Rieckmann.   

Abstract

The multiple sclerosis-associated retrovirus (MSRV), originally identified in cell cultures from patients with multiple sclerosis (MS), is closely related to the human endogenous retrovirus family W (HERV-W). Recently, HERV-W gag and env protein expression was demonstrated in MS lesions in situ. Here, the authors show that HERV-W gag and env proteins are induced by herpes simplex virus type 1 (HSV-1) in neuronal and brain endothelial cells in vitro. The transactivation of HERV-W proteins by HSV-1 could enhance their potential oligodendrotoxic and immunopathogenic effects, representing a mechanism by which HSV-1, and possibly also other herpesviruses associated with MS, may be linked to the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595376     DOI: 10.1080/13550280600614973

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  39 in total

Review 1.  Multiple sclerosis in time and space--geographic clues to cause.

Authors:  J F Kurtzke
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

2.  Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.

Authors:  Michael H Barnett; John W Prineas
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

3.  Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis.

Authors:  J A Garson; P W Tuke; P Giraud; G Paranhos-Baccala; H Perron
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

Review 4.  Viruses and multiple sclerosis.

Authors:  A G Dalgleish
Journal:  Acta Neurol Scand Suppl       Date:  1997

5.  Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia.

Authors:  H Karlsson; S Bachmann; J Schröder; J McArthur; E F Torrey; R H Yolken
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

6.  Molecular basis of the interactions between herpes simplex viruses and HIV-1.

Authors:  G Palù; L Benetti; A Calistri
Journal:  Herpes       Date:  2001-07

7.  Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination.

Authors:  Joseph M Antony; Guido van Marle; Wycliffe Opii; D Allan Butterfield; François Mallet; Voon Wee Yong; John L Wallace; Robert M Deacon; Kenneth Warren; Christopher Power
Journal:  Nat Neurosci       Date:  2004-09-26       Impact factor: 24.884

8.  Transactivation of the human endogenous retrovirus K long terminal repeat by herpes simplex virus type 1 immediate early protein 0.

Authors:  Hyun Jin Kwun; Hae Jin Han; Woo Jung Lee; Hee Soo Kim; Kyung Lib Jang
Journal:  Virus Res       Date:  2002-06       Impact factor: 3.303

9.  Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.

Authors:  L Xu; T J Wrona; J P Dudley
Journal:  Virology       Date:  1996-01-15       Impact factor: 3.616

10.  Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis.

Authors:  H Perron; M Suh; B Lalande; B Gratacap; A Laurent; P Stoebner; J M Seigneurin
Journal:  J Gen Virol       Date:  1993-01       Impact factor: 3.891

View more
  46 in total

Review 1.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

2.  Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.

Authors:  Giuseppe Mameli; Luciana Poddighe; Alessandra Mei; Elena Uleri; Stefano Sotgiu; Caterina Serra; Roberto Manetti; Antonina Dolei
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

3.  An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.

Authors:  Sandrine Levet; Julie Medina; Julie Joanou; Amandine Demolder; Nelly Queruel; Kevin Réant; Matthieu Normand; Marine Seffals; Julie Dimier; Raphaële Germi; Thomas Piofczyk; Jacques Portoukalian; Jean-Louis Touraine; Hervé Perron
Journal:  JCI Insight       Date:  2017-09-07

4.  Epstein-Barr Virus and MS:Causality or Association?

Authors:  Sk Ludwin; S Jacobson
Journal:  Int MS J       Date:  2011-05

Review 5.  The retrovirus/superantigen hypothesis of multiple sclerosis.

Authors:  Alexander Emmer; Martin S Staege; Malte E Kornhuber
Journal:  Cell Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.046

Review 6.  The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation.

Authors:  Hervé Perron; Alois Lang
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

7.  Influenza A virus transactivates the mouse envelope gene encoding syncytin B and its regulator, glial cells missing 1.

Authors:  Linnéa Asp; Christoffer Nellåker; Håkan Karlsson
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

8.  Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.

Authors:  Klemens Ruprecht; Felix Gronen; Marlies Sauter; Barbara Best; Peter Rieckmann; Nikolaus Mueller-Lantzsch
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

Review 9.  Human endogenous retroviruses and the nervous system.

Authors:  Renée N Douville; Avindra Nath
Journal:  Handb Clin Neurol       Date:  2014

10.  B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.

Authors:  Tomasz Brudek; Tove Christensen; Lars Aagaard; Thor Petersen; Hans J Hansen; Anné Møller-Larsen
Journal:  Retrovirology       Date:  2009-11-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.